AEVI GENOMIC Balance Sheet - Annual (NASDAQ:GNMX)

Add to My Stocks
$1.2 $0.06 (5.26%) GNMX stock closing price Jun 22, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our AEVI GENOMIC stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our AEVI GENOMIC stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. AEVI GENOMIC had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at AEVI GENOMIC operating cash flow and AEVI GENOMIC revenue also. AEVI GENOMIC debt to equity ratio is .

View latest 10 year balance sheet data to check AEVI GENOMIC financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Cash33.72M39.83M53.06M33.28M22.39M6.43M4.99M
Marketable Securities-------
Receivables------1.12M
Inventory-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets-------
Total Current Assets
34.62M40.17M53.81M33.6M22.59M6.97M6.11M
Property Plant & Equipment-1.8M1.58M1.49M1.13M--
Accumulated Depreciation-1.42M1.15M1M---
Net Property Plant & Equipment
-------
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Intangibles-------
Deposits & Other Assets-------
Total Assets
34.76M40.56M54.25M34.28M23.08M7.7M6.86M
Notes Payable-------
Accounts Payable--1.32M1.07M1.06M--
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses3.19M5.44M2.58M2.56M1.95M1.47M-
Income Taxes Payable-------
Other Current Liabilities------1.15M
Total Current Liabilities
4.14M5.58M3.9M3.63M3.01M2.35M2.05M
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt-------
Non-Current Capital Leases-------
Other Long-Term Liabilities----1.65M3.42M1.8M
Total Liabilities
4.14M5.58M3.9M4.61M4.66M5.77M3.86M
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus245.59M215M188.47M129.79M100.12M66.5M52.5M
Retained Earnings-214.97M-180.03M-138.13M-100.13M-81.7M-64.57M-49.5M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity30.62M34.97M50.35M29.66M18.42M1.93M2.99M
Total Liabilities & Shareholders Equity34.76M40.56M54.25M34.28M23.08M7.7M6.86M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at AEVI GENOMIC historical stock prices and the current AEVI GENOMIC stock price can tell you how the stock price has moved, whereas the AEVI GENOMIC PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: GNMX total assets, which was at $34.76M for 2017 is a balance sheet item representing value of what AEVI GENOMIC owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for AEVI GENOMIC is $4.14M. Shareholders' equity comes under liabilities as it is money the company owes the holders of GNMX stock.

AEVI GENOMIC Balance Sheet - Key Ratios